James E Flynn Insider Trading $NURO NeuroMetrix, Inc.
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
James E Flynn in NeuroMetrix, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 781,833 shares
Current Value: $539,465
Latest Transaction: Dec 14 2010
$NURO Market Capitalization: $3.81M
$NURO Previous Close: $0.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James E Flynn in NeuroMetrix, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.51 | 11,557 | 5,894 | 781,833 | 793.4 K to 781.8 K (-1.46 %) |
| Dec 14 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.51 | 6,443 | 3,286 | 435,887 | 442.3 K to 435.9 K (-1.46 %) |
| Dec 14 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.50 | 8,925 | 4,463 | 793,390 | 802.3 K to 793.4 K (-1.11 %) |
| Dec 14 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.50 | 4,975 | 2,488 | 442,330 | 447.3 K to 442.3 K (-1.11 %) |
| Dec 14 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.51 | 192,615 | 98,234 | 802,315 | 994.9 K to 802.3 K (-19.36 %) |
| Dec 14 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.51 | 107,385 | 54,766 | 447,305 | 554.7 K to 447.3 K (-19.36 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 20,995 | 12,177 | 994,930 | 1 M to 994.9 K (-2.07 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 11,705 | 6,789 | 554,690 | 566.4 K to 554.7 K (-2.07 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.56 | 88,905 | 49,787 | 1,015,925 | 1.1 M to 1 M (-8.05 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.56 | 49,565 | 27,756 | 566,395 | 616 K to 566.4 K (-8.05 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.60 | 290,692 | 174,415 | 1,104,830 | 1.4 M to 1.1 M (-20.83 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.60 | 162,064 | 97,238 | 615,960 | 778 K to 616 K (-20.83 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.55 | 1,011 | 556 | 1,395,522 | 1.4 M to 1.4 M (-0.07 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.55 | 563 | 310 | 778,024 | 778.6 K to 778 K (-0.07 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.56 | 128,003 | 71,682 | 1,396,533 | 1.5 M to 1.4 M (-8.40 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.56 | 71,362 | 39,963 | 778,587 | 849.9 K to 778.6 K (-8.40 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.53 | 10,209 | 5,411 | 1,524,536 | 1.5 M to 1.5 M (-0.67 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.53 | 5,691 | 3,016 | 849,949 | 855.6 K to 849.9 K (-0.67 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 193 | 114 | 1,534,745 | 1.5 M to 1.5 M (-0.01 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 107 | 63 | 855,640 | 855.7 K to 855.6 K (-0.01 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 34,724 | 20,140 | 1,534,938 | 1.6 M to 1.5 M (-2.21 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 19,358 | 11,228 | 855,747 | 875.1 K to 855.7 K (-2.21 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 4,816 | 2,793 | 1,569,662 | 1.6 M to 1.6 M (-0.31 %) |
| Nov 18 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 2,684 | 1,557 | 875,105 | 877.8 K to 875.1 K (-0.31 %) |
| Oct 28 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 63,563 | 37,502 | 1,574,478 | 1.6 M to 1.6 M (-3.88 %) |
| Oct 28 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 35,437 | 20,908 | 877,789 | 913.2 K to 877.8 K (-3.88 %) |
| Sep 28 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 129 | 75 | 1,638,041 | 1.6 M to 1.6 M (-0.01 %) |
| Sep 28 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 71 | 41 | 913,226 | 913.3 K to 913.2 K (-0.01 %) |
| Sep 28 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 12,842 | 7,448 | 1,638,170 | 1.7 M to 1.6 M (-0.78 %) |
| Sep 28 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 7,158 | 4,152 | 913,297 | 920.5 K to 913.3 K (-0.78 %) |
| Sep 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 1,443 | 851 | 1,651,012 | 1.7 M to 1.7 M (-0.09 %) |
| Sep 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 804 | 474 | 920,455 | 921.3 K to 920.5 K (-0.09 %) |
| Sep 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 2 | 1 | 1,652,455 | 1.7 M to 1.7 M (0.00 %) |
| Sep 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 28,553 | 16,846 | 1,652,457 | 1.7 M to 1.7 M (-1.70 %) |
| Sep 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 15,917 | 9,391 | 921,259 | 937.2 K to 921.3 K (-1.70 %) |
| Sep 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 4,559 | 2,644 | 1,681,010 | 1.7 M to 1.7 M (-0.27 %) |
| Sep 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 2,541 | 1,474 | 937,176 | 939.7 K to 937.2 K (-0.27 %) |
| Sep 17 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 192,616 | 111,717 | 1,685,569 | 1.9 M to 1.7 M (-10.26 %) |
| Sep 17 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.58 | 107,384 | 62,283 | 939,717 | 1 M to 939.7 K (-10.26 %) |
| Sep 17 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 256,821 | 151,524 | 1,878,185 | 2.1 M to 1.9 M (-12.03 %) |
| Sep 17 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.59 | 143,179 | 84,476 | 1,047,101 | 1.2 M to 1 M (-12.03 %) |
| Sep 17 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.60 | 40,129 | 24,077 | 2,135,006 | 2.2 M to 2.1 M (-1.84 %) |
| Sep 17 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.60 | 22,371 | 13,423 | 1,190,280 | 1.2 M to 1.2 M (-1.84 %) |
| Aug 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.89 | 3,780 | 3,364 | 2,175,135 | 2.2 M to 2.2 M (-0.17 %) |
| Aug 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.89 | 2,107 | 1,875 | 1,212,651 | 1.2 M to 1.2 M (-0.17 %) |
| Aug 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.78 | 642,053 | 500,801 | 2,178,915 | 2.8 M to 2.2 M (-22.76 %) |
| Aug 23 2010 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Sell | S | 0.78 | 357,947 | 279,199 | 1,214,758 | 1.6 M to 1.2 M (-22.76 %) |
| Sep 11 2009 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Option Exercise | P | 2.20 | 1,544,750 | 3,398,450 | 1,544,750 | |
| Sep 11 2009 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Option Exercise | P | 2.20 | 876,489 | 1,928,276 | 876,489 | |
| Sep 11 2009 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Buy | P | 2.00 | 1,626,053 | 3,252,106 | 2,820,968 | 1.2 M to 2.8 M (+136.08 %) |
| Sep 11 2009 | NURO | NeuroMetrix, Inc. | Flynn James E | 10% Owner | Buy | P | 2.00 | 922,620 | 1,845,240 | 1,572,705 | 650.1 K to 1.6 M (+141.92 %) |
Page: 1